Treatments:Cancer
From Proteopedia
(Difference between revisions)
| Line 8: | Line 8: | ||
=====Anti-melanoma [[Monoclonal Antibody]]===== | =====Anti-melanoma [[Monoclonal Antibody]]===== | ||
* Pembrolizumab - Generic: [[Keytruda]] | * Pembrolizumab - Generic: [[Keytruda]] | ||
| + | =====Anti-prostate cancer===== | ||
| + | * [[Bicalutamide]] - Generic: Casodex | ||
=====B-Raf Kinase Inhibitor===== | =====B-Raf Kinase Inhibitor===== | ||
* Zelboraf - Generic: Vemurafenib (Formerly: PLX-4032) | * Zelboraf - Generic: Vemurafenib (Formerly: PLX-4032) | ||
Revision as of 11:41, 6 January 2025
Anti-CD20 Monoclonal Antibody
Anti-melanoma Monoclonal Antibody
Anti-prostate cancer
B-Raf Kinase Inhibitor
ChemotherapyDihydrofolate Reductase Inhibitor
Epidermal Growth Factor Receptor Inhibitors
Estrogen Receptor Modulator
mTOR inhibitor
Multiple Receptor Tyrosine kinase (VEGFR, PDGFR, EGFR, KIT, Abl) Inhibitors
Vascular Endothelial Growth Factor Inhibitor
Poly ADP ribose polymerase (PARP) inhibitorsCyclin-dependent kinases inhibitors
See also Anti-cancer drugs and Anticancer drugs |
Proteopedia Page Contributors and Editors (what is this?)
David Canner, Michal Harel, Alexander Berchansky, Karsten Theis
